Senior Publishing Specialist, Regulatory Affairs
Scottsdale, Az, Us
• Acted as primary liaison to coordinate the outsourcing of large eCTD submissions to Quintiles, including an original 505(b)(1) New Drug Application (NDA) of approximately 65,000 pages.• Published an initial IND and 505(b)(2) NDA using in-house publishing software eCTDXPress, following ICH guidelines regarding the structure and content of clinical study reports.• Prepared lifecycle submissions for over 27 products (in both paper and eCTD format), including supplements, periodic safety updates, and general correspondence, for INDs, NDAs, and Abbreviated New Drug Applications (ANDAs), authored in Octagon’s StartingPoint templates.• Created eCopies to accompany paper submissions to the FDA Center for Devices and Radiological Health (CDRH) for medical device products under Investigational Device Exemption (IDE) and Premarket Approval (PMA) applications.• Collaborated with Creative Services Department to prepare promotional material for submission to the FDA Office of Prescription Drug Promotion (OPDP), averaging over 500 individual promotional pieces (in both paper and electronic format) every year.• Navigated the web-based eFiles system of Health Canada’s Pharmaceutical Advertising Advisory Board (PAAB) to upload promotional material (in English and French) for review and acceptance.• Provided cross-functional training to Pharmacovigilance and Compliance Departments on utilizing the ESG for expedited adverse event reporting and submittal of drug sample information.• Archived submissions, FDA correspondence, and contact reports in 21 CFR Part 11-compliant document management system (i.e., Documentum).